Xiansheng Huang
Changsha, 410205, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Multi-Target Tracking with Collaborative Roadside Units Under Foggy Conditions.
Journal: Sensors (Basel, Switzerland)
Published: December 01, 2025
Olanzapine causes non-alcoholic fatty liver disease via inhibiting the secretion of apolipoprotein A5.
Journal: Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences
Published: July 15, 2022
Sodium-glucose cotransporter protein-2 inhibitors and glucagon-like peptide-1 receptor agonists versus thiazolidinediones for non-alcoholic fatty liver disease: A network meta-analysis.
Journal: Acta diabetologica
Published: October 17, 2021
Metformin Ameliorates Hepatic Steatosis induced by olanzapine through inhibiting LXRα/PCSK9 pathway.
Metformin Ameliorates Hepatic Steatosis induced by olanzapine through inhibiting LXRα/PCSK9 pathway.
Journal: Scientific reports
Published: September 15, 2021
H2O2 gel bleaching induces cytotoxicity and pain conduction in dental pulp stem cells via intracellular reactive oxygen species on enamel/dentin disc.
Journal: PloS one
Published: June 09, 2021
TRPA1 triggers hyperalgesia and inflammation after tooth bleaching.
Journal: Scientific reports
Published: April 30, 2021
Olanzapine leads to nonalcoholic fatty liver disease through the apolipoprotein A5 pathway.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: January 29, 2021
Nicorandil, a promising drug for the prevention of percutaneous coronary artery intervention-related myocardial injury and infarction in patients with stable coronary artery disease.
Journal: International journal of cardiology
Published: February 13, 2020
Remineralization of demineralized dentin induced by bioactive glass NovaMin
Journal: Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences
Published: August 16, 2018
Effect of Betahistine and Metformin on Antipsychotic-Induced Weight Gain: An Analysis of Two Clinical Trials.
Journal: Frontiers in psychiatry
Published: May 24, 2018
Metformin reduces plasma triglycerides in ob/ob obese mice via inhibiting the hepatic apoA5 expression
Journal: Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences
Published: January 11, 2018
Last Updated: 09/26/2026